ÀºÇòÅâÂÊ

ÀºÇòÅâÂÊ Services FAQ Contact Us 0
Home Pharmaceuticals COVID-19 Diagnostics Market Size, Share, Analysis and Forecast to 2029
COVID-19 Diagnostics Market

COVID-19 Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents & Kits, Services), By Sample Type (Nasopharyngeal (NP) swabs, Oropharyngeal (OP) swabs, Nasal swabs, Blood, Others), By Mode of Testing (Molecular Testing(PCR), Antigen-based Testing, Serology Testing (Antibody), Others), By End-Users (Laboratories, Hospitals, Diagnostic Centers and Clinics, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRPH1215DR
Author : ÀºÇòÅâÂÊ
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global COVID-19 Diagnostics Market Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. U.S.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Canada
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. U.K.
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. UAE
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Instruments
        1. By Value
      3. Reagents & Kits
        1. By Value
      4. Services
        1. By Value
    3. By Sample Type
      1. Introduction
        1. Sample Type By Value
      2. Nasopharyngeal (NP) swabs
        1. By Value
      3. Oropharyngeal (OP) swabs
        1. By Value
      4. Nasal swabs
        1. By Value
      5. Blood
        1. By Value
      6. Others
        1. By Value
    4. By Mode of Testing
      1. Introduction
        1. Mode of Testing By Value
      2. Molecular Testing(PCR)
        1. By Value
      3. Antigen-based Testing
        1. By Value
      4. Serology Testing (Antibody)
        1. By Value
      5. Others
        1. By Value
    5. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Laboratories
        1. By Value
      3. Hospitals
        1. By Value
      4. Diagnostic Centers and Clinics
        1. By Value
      5. Others
        1. By Value
    6. Brazil
      1. By Product
        1. Introduction
          1. Product By Value
        2. Instruments
          1. By Value
        3. Reagents & Kits
          1. By Value
        4. Services
          1. By Value
      2. By Sample Type
        1. Introduction
          1. Sample Type By Value
        2. Nasopharyngeal (NP) swabs
          1. By Value
        3. Oropharyngeal (OP) swabs
          1. By Value
        4. Nasal swabs
          1. By Value
        5. Blood
          1. By Value
        6. Others
          1. By Value
      3. By Mode of Testing
        1. Introduction
          1. Mode of Testing By Value
        2. Molecular Testing(PCR)
          1. By Value
        3. Antigen-based Testing
          1. By Value
        4. Serology Testing (Antibody)
          1. By Value
        5. Others
          1. By Value
      4. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Laboratories
          1. By Value
        3. Hospitals
          1. By Value
        4. Diagnostic Centers and Clinics
          1. By Value
        5. Others
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. COVID-19 Diagnostics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Hologic Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Thermo Fisher Scientific, Inc.
    3. Hoffman-La Roche Ltd.
    4. Perkin Elmer, Inc.
    5. Laboratory Corporation of America Holdings (LabCorp)
    6. bioMérieux SA
    7. Danaher
    8. Mylab Discovery Solutions Pvt. Ltd.
    9. Neuberg Diagnostics
    10. Quest Diagnostics
    11. Abbott
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Clinical Diagnostics Market Size The global clinical diagnostics market size was valued at USD 84.18 billion in 2024 and is projected to reach from USD 89.63 billion in 2025 to USD 148.12 billion by 2033, exhibiting a CAGR of 6.48% during the foreca
Buy Now
Global Report
Companion Diagnostics Market Size The global companion diagnostics market size was valued at USD 5.87 billion in 2024 and is projected to reach from USD 6.62 billion in 2025 to USD 17.34 billion by 2033, growing at a CAGR of 12.8% % during the forec
Buy Now
Global Report
In Vitro Diagnostics Market Size The global in vitro diagnostics market size was valued at USD 73 billion in 2024 and is projected to reach from USD 77.5 billion in 2025 to USD 125.12 billion by 2033, growing at a CAGR of 6.19% during the forec
Buy Now
Global Report
TB Diagnostics Market Size The global TB diagnostics market size was valued at USD 1.4 Billion in 2024 and is anticipated to grow from USD 1.48 Billion in 2025 to reach USD 2.28 Billion by 2033, exhibiting a CAGR of 5.56% during the forecast period
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

ÀºÇòÅâÂÊ
© Copyright . All rights Reserved.